Are Thyrocare Tech. latest results good or bad?

Thyrocare Technologies has reported its financial results for the quarter ending June 2025, showcasing notable growth across several key metrics. The company achieved a Profit Before Tax (PBT) of Rs 45.83 crore, which reflects a year-on-year growth of 53.07%. Additionally, the Profit After Tax (PAT) reached Rs 38.93 crore, indicating a robust increase of 61.1% compared to the same quarter last year.
Net sales for the quarter hit Rs 193.03 crore, marking a year-on-year growth of 23.02%, the highest growth rate recorded in the last five quarters. The Operating Profit (PBDIT) also saw significant growth, reaching Rs 57.77 crore. Earnings per Share (EPS) stood at Rs 7.35, the highest in the last five quarters, suggesting enhanced profitability for shareholders.

While there was an increase in non-operating income to Rs 4.65 crore, it is important to consider that this increase may not be sustainable in the long term. Overall, Thyrocare Technologies has demonstrated a solid financial performance, reinforcing its strong position within the healthcare services sector. Furthermore, the company saw an adjustment in its evaluation, reflecting the positive operational trends observed in its financial results.